Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-20

Clinical Trial Update: Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of bisoprolol and verapamil for symptomatic non-obstructive hypertrophic cardiomyopathy, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisoprolol (Bisoprolol)
  • Verapamil (verapamil)

Snippet

Sponsor: Morten Steen Kvistholm Jensen | Conditions: Non-obstructive Hypertrophic Cardiomyopathy | Phase 4 | Status: RECRUITING